{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:06:04Z","timestamp":1789610764772,"version":"build-2803163510"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neuroscience.2025.01.038","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T19:51:44Z","timestamp":1737575504000},"page":"298-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["MicroRNAs in Parkinson\u2019s disease: From pathogenesis to diagnostics and therapeutic strategies"],"prefix":"10.1016","volume":"568","author":[{"given":"Dongying","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neuroscience.2025.01.038_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12249-024-02906-7","article-title":"Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells","volume":"25","author":"Ahmadi","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115408","article-title":"Targeted protein degradation for the treatment of Parkinson's disease: Advances and future perspective","volume":"166","author":"Amirian","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.01.038_b0015","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s11064-024-04223-8","article-title":"Intranasal AdipoRon Mitigated Anxiety and Depression-Like Behaviors in 6-OHDA-Induced Parkinson 's Disease Rat Model: Going Beyond Motor Symptoms","volume":"49","author":"Azizifar","year":"2024","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/01616412.2020.1726584","article-title":"Effects of miR-199a on autophagy by targeting glycogen synthase kinase 3\u03b2 to activate PTEN\/AKT\/mTOR signaling in an MPP(+) in vitro model of Parkinson's disease","volume":"42","author":"Ba","year":"2020","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136094","article-title":"microRNA-106b-containing extracellular vesicles affect autophagy of neurons by regulating CDKN2B in Parkinson's disease","volume":"760","author":"Bai","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.01.038_b0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s13346-019-00645-y","article-title":"Delivery of therapeutic miRNA using polymer-based formulation","volume":"9","author":"Ban","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0035","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.matpr.2022.10.311","article-title":"Nanotherapeutics a promising approach for treatment of Parkinson\u2019s disease","volume":"69","author":"Bhalothia","year":"2022","journal-title":"Mater. Today Proc."},{"issue":"s2","key":"10.1016\/j.neuroscience.2025.01.038_b0040","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.3233\/JPD-212674","article-title":"Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral Vectors","volume":"11","author":"Bj\u00f6rklund","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"22","key":"10.1016\/j.neuroscience.2025.01.038_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223629","article-title":"Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development","volume":"11","author":"Bose","year":"2022","journal-title":"Cells"},{"issue":"17\u201318","key":"10.1016\/j.neuroscience.2025.01.038_b0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum. Gene Ther."},{"issue":"13","key":"10.1016\/j.neuroscience.2025.01.038_b0055","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/acschemneuro.1c00096","article-title":"Intranasal Carnosine Mitigates \u03b1-Synuclein Pathology and Motor Dysfunction in the Thy1-aSyn Mouse Model of Parkinson's Disease","volume":"12","author":"Brown","year":"2021","journal-title":"ACS Chem. Nerosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/acsami.3c12680","article-title":"Inorganic Nanoparticles Change Cancer-Cell-Derived Extracellular Vesicle Secretion Levels and Cargo Composition, Resulting in Secondary Biological Effects","volume":"16","author":"Buttiens","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.18632\/aging.102649","article-title":"Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1","volume":"12","author":"Cai","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0075","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.omtn.2019.12.024","article-title":"MicroRNAs: Possible Regulatory Molecular Switch Controlling the BBB Microenvironment","volume":"19","author":"Chakraborty","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.01.038_b0080","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1007\/s10072-024-07439-2","article-title":"Exosomal microRNAs in Parkinson's disease: insights into biomarker potential and disease pathology","volume":"45","author":"Chandran","year":"2024","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0085","first-page":"484","article-title":"Research Progress of microRNA-7\/124\/155 in Parkinson's Disease","volume":"45","author":"Chen","year":"2023","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0090","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820907016","article-title":"MiR-142-5p Protects Against 6-OHDA-Induced SH-SY5Y Cell Injury by Downregulating BECN1 and Autophagy","volume":"18","author":"Chen","year":"2020","journal-title":"Dose Response"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12929-024-01055-0","article-title":"Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials","volume":"31","author":"Chen","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2319412","article-title":"Baicalein Mediates Mitochondrial Autophagy via miR-30b and the NIX\/BNIP3 Signaling Pathway in Parkinson's Disease","volume":"2021","author":"Chen","year":"2021","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fncel.2019.00399","article-title":"Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade","volume":"13","author":"Chiu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0110","first-page":"16","article-title":"Recombinant Adeno-Associated Virus-Mediated microRNA Delivery into the Postnatal Mouse Brain Reveals a Role for miR-134 in Dendritogenesis in Vivo","volume":"3","author":"Christensen","year":"2010","journal-title":"Front. Neural Circuits"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.01.038_b0115","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1007\/s12035-017-0791-0","article-title":"Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b\/c in Neuronal Cells","volume":"55","author":"Consales","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114198","article-title":"The BCL-2 family members NOXA and BIM mediate fluorizoline-induced apoptosis in multiple myeloma cells","volume":"180","author":"Cosialls","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/mds.27935","article-title":"Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease","volume":"35","author":"Cressatti","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuro.2024.02.005","article-title":"Neuronal exosomal miRNAs modulate mitochondrial functions and cell death in bystander neuronal cells under Parkinson's disease stress conditions","volume":"101","author":"Currim","year":"2024","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/mps4010010","article-title":"Recent Advances in miRNA Delivery Systems","volume":"4","author":"Dasgupta","year":"2021","journal-title":"Methods Protoc"},{"issue":"19","key":"10.1016\/j.neuroscience.2025.01.038_b0140","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.038_b0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11064-019-02910-5","article-title":"Pramipexole Inhibits MPP(+)-Induced Neurotoxicity by miR-494-3p\/BDNF","volume":"45","author":"Deng","year":"2020","journal-title":"Neurochem. Res."},{"issue":"21","key":"10.1016\/j.neuroscience.2025.01.038_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113383","article-title":"AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery","volume":"23","author":"Di Scala","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5186252","article-title":"Inhibition of miR-421 Preserves Mitochondrial Function and Protects against Parkinson's Disease Pathogenesis via Pink1\/Parkin-Dependent Mitophagy","volume":"2022","author":"Dong","year":"2022","journal-title":"Dis. Markers"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.01.038_b0160","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s11064-024-04130-y","article-title":"MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease","volume":"49","author":"Esteves","year":"2024","journal-title":"Neurochem. Res."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.01.038_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126389","article-title":"Adeno-Associated Viral Vectors as Versatile Tools for Parkinson's Research, Both for Disease Modeling Purposes and for Therapeutic Uses","volume":"22","author":"Fajardo-Serrano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134567","article-title":"Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease","volume":"714","author":"Fine","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fncel.2014.00182","article-title":"miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway","volume":"8","author":"Fragkouli","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","article-title":"MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling","volume":"237","author":"Fujita","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118449","article-title":"Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson's disease model","volume":"567","author":"Gan","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0190","first-page":"49","article-title":"Short-term Tolerance of Nasally-administered NeuroEPO in Patients with Parkinson Disease","volume":"23","author":"Garc\u00eda-Llano","year":"2021","journal-title":"MEDICC Rev."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.01.038_b0195","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13840","article-title":"Regulation of Hsa-miR-4639-5p expression and its potential role in the pathogenesis of Parkinson's disease","volume":"22","author":"He","year":"2023","journal-title":"Aging Cell"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.01.038_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137167","article-title":"MicroRNA-Based Diagnosis and Therapy","volume":"23","author":"Ho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.04.010","article-title":"Intranasal Administration of Umbilical Cord Mesenchymal Stem Cell Exosomes Alleviates Parkinson's Disease","volume":"549","author":"Huang","year":"2024","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.038_b0210","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14763","article-title":"Autophagy-associated non-coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis","volume":"30","author":"Hussain","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.01.038_b0215","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/1570159X21666221121094343","article-title":"Surgical Advances in Parkinson's Disease","volume":"22","author":"Hvingelby","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fnagi.2020.00004","article-title":"Strategies for the Treatment of Parkinson's Disease: Beyond Dopamine","volume":"12","author":"Iarkov","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.01.038_b0225","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/1566524023666220817145638","article-title":"The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target","volume":"23","author":"Jaberi","year":"2023","journal-title":"Curr. Mol. Med."},{"issue":"16","key":"10.1016\/j.neuroscience.2025.01.038_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169361","article-title":"Lipid Nanoparticles: Promising Treatment Approach for Parkinson's Disease","volume":"23","author":"Jagaran","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.01.038_b0235","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41594-020-0465-x","article-title":"Decoding mRNA translatability and stability from the 5' UTR","volume":"27","author":"Jia","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0240","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2023-332921","article-title":"Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease","author":"Jiang","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.038_b0245","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1567201820666230523114259","article-title":"Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review","volume":"21","author":"Kapoor","year":"2024","journal-title":"Curr. Drug Deliv."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0250","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1570159X20666220507022701","article-title":"Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy","volume":"21","author":"Khatri","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.038_b0255","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.7150\/thno.84165","article-title":"Intranasal delivery of mitochondrial protein humanin rescues cell death and promotes mitochondrial function in Parkinson's disease","volume":"13","author":"Kim","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-016-0121-4","article-title":"miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)","volume":"11","author":"Kim","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.038_b0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s12276-021-00562-6","article-title":"Effects of innate immune receptor stimulation on extracellular \u03b1-synuclein uptake and degradation by brain resident cells","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.038_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105307","article-title":"Potential Exosome Biomarkers for Parkinson's Disease Diagnosis: A Systematic Review and Meta-Analysis","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"D1","key":"10.1016\/j.neuroscience.2025.01.038_b0275","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.01.038_b0280","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2202721","article-title":"Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease","volume":"388","author":"Krishna","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.038_b0285","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2018.03.041","article-title":"MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN\/Akt\/mTOR signaling pathway","volume":"675","author":"Li","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0295","article-title":"HMGA1 Induction of miR-103\/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson's Disease","volume":"14","author":"Li","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0300","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","article-title":"Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0305","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1002\/mgg3.1189","article-title":"MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease","volume":"8","author":"Li","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110012","article-title":"CircZNF208 enhances the sensitivity to X-rays instead of carbon-ions through the miR-7-5p \/SNCA signal axis in non-small-cell lung cancer cells","volume":"84","author":"Liu","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0315","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.12659\/MSM.900218","article-title":"MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)\/c-Jun N-Terminal Kinases (JNK) Signaling Pathways","volume":"23","author":"Liu","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.038_b0320","article-title":"Exosome-Based Carrier for RNA Delivery","volume":"15","author":"Lu","year":"2023","journal-title":"Progress and Challenges. Pharmaceutics"},{"issue":"20","key":"10.1016\/j.neuroscience.2025.01.038_b0325","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1021\/acschemneuro.0c00375","article-title":"Rosmarinic Acid Alleviates Inflammation, Apoptosis, and Oxidative Stress through Regulating miR-155-5p in a Mice Model of Parkinson's Disease","volume":"11","author":"Lv","year":"2020","journal-title":"ACS Chem. Nerosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0330","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jnc.15299","article-title":"MicroRNA-3473b regulates the expression of TREM2\/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease","volume":"157","author":"Lv","year":"2021","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.01.038_b0335","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1080\/15548627.2019.1618100","article-title":"Toward the function of mammalian ATG12-ATG5-ATG16L1 complex in autophagy and related processes","volume":"15","author":"Lystad","year":"2019","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030746","article-title":"Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery","volume":"15","author":"Maher","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.038_b0345","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40259-024-00646-5","article-title":"Recombinant Antibody Fragments for Immunotherapy of Parkinson's Disease","volume":"38","author":"Manoutcharian","year":"2024","journal-title":"BioDrugs"},{"issue":"19","key":"10.1016\/j.neuroscience.2025.01.038_b0350","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.2174\/1381612826666200316154300","article-title":"Current Status and Challenges in Rotigotine Delivery","volume":"26","author":"Md","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"15","key":"10.1016\/j.neuroscience.2025.01.038_b0355","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function","volume":"20","author":"Mi\u00f1ones-Moyano","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.01.038_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111901","article-title":"miRNA Delivery by Nanosystems: State of the Art and Perspectives","volume":"13","author":"Moraes","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10423","key":"10.1016\/j.neuroscience.2025.01.038_b0365","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110002","article-title":"Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: Targeting the GRP78\/PERK\/eIF2\u03b1\/CHOP pathway and miR-211-5p","volume":"362","author":"Motawi","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.01.038_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111560","article-title":"Dynamic Variations of 3'UTR Length Reprogram the mRNA Regulatory Landscape","volume":"9","author":"Navarro","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.660379","article-title":"MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review","volume":"15","author":"Nies","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0390","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","article-title":"Novel targeted therapies for Parkinson's disease","volume":"27","author":"Ntetsika","year":"2021","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.01.038_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/biom10060945","article-title":"Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology","volume":"10","author":"Oliveira","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0400","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1871527321666220111152756","article-title":"A Comprehensive Study of miRNAs in Parkinson's Disease: Diagnostics and Therapeutic Approaches","volume":"22","author":"Owais","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.01.038_b0405","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/00207454.2020.1784165","article-title":"Serum microRNA expression levels in Turkish patients with Parkinson's disease","volume":"131","author":"Ozdilek","year":"2021","journal-title":"Int. J. Neurosci."},{"issue":"21","key":"10.1016\/j.neuroscience.2025.01.038_b0410","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213445","article-title":"Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes","volume":"11","author":"Padilla-God\u00ednez","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110328","article-title":"MiR-135a-5p and Mst1 regulate MPP+-1 induced apoptosis and autophagy in Parkinson's disease model in vitro","volume":"94","author":"Qin","year":"2022","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0420","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","article-title":"Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives","volume":"29","author":"Rahimi Darehbagh","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.01.038_b0425","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/acn3.51146","article-title":"Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients","volume":"7","author":"Ravanidis","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.01.038_b0430","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/17425247.2019.1684895","article-title":"Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment?","volume":"16","author":"Rehman","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0435","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-024-02125-z","article-title":"MicroRNAs Modulating Neuroinflammation in Parkinson's disease","author":"Saadh","year":"2024","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0440","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10571-019-00761-w","article-title":"CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease","volume":"40","author":"Safari","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0445","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2023.04.021","article-title":"Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease","volume":"358","author":"Saha","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0450","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gene.2018.06.061","article-title":"Modulation in miR-200a\/SIRT1axis is associated with apoptosis in MPP(+)-induced SH-SY5Y cells","volume":"674","author":"Salimian","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0455","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2016.06.005","article-title":"MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0460","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnmol.2017.00328","article-title":"Modulation of Alpha-synuclein Expression and Associated Effects by MicroRNA Let-7 in Transgenic C. elegans","volume":"10","author":"Shamsuzzama","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.038_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100997","article-title":"miR-135b: An emerging player in cardio-cerebrovascular diseases","volume":"14","author":"Shao","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2023.100032","article-title":"Exosome as drug delivery system: Current advancements","volume":"3","author":"Sharma","year":"2024","journal-title":"Extracellular Vesicle"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0475","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neures.2020.04.003","article-title":"Astaxanthin suppresses endoplasmic reticulum stress and protects against neuron damage in Parkinson's disease by regulating miR-7\/SNCA axis","volume":"165","author":"Shen","year":"2021","journal-title":"Neurosci. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0480","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1567","article-title":"miR-30b protects nigrostriatal dopaminergic neurons from MPP(+)-induced neurotoxicity via SNCA","volume":"10","author":"Shen","year":"2020","journal-title":"Brain Behav."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.01.038_b0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075475","article-title":"Dual regulation of the lin-14 target mRNA by the lin-4 miRNA","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0490","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12640-020-00290-1","article-title":"Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease","volume":"39","author":"Simorgh","year":"2021","journal-title":"Neurotox. Res."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.01.038_b0495","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1007\/s12035-021-02392-z","article-title":"Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson's Disease Treatment","volume":"58","author":"Simorgh","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0500","first-page":"9","article-title":"Recent developments in the treatment of","volume":"F1000Res","author":"Stoker","year":"2020","journal-title":"Parkinson's Disease."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0505","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fnmol.2018.00381","article-title":"MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson's Disease","volume":"11","author":"Sun","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0510","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tiv.2017.10.003","article-title":"Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with \u03b1-synuclein overexpression and risk of idiopathic Parkinson's disease","volume":"46","author":"Tarale","year":"2018","journal-title":"Toxicol. In Vitro"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.01.038_b0515","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0520","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040841","article-title":"The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson's Disease","volume":"9","author":"Titze-de-Almeida","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0525","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1566523218666180430121323","article-title":"miR-7 Replacement Therapy in Parkinson's Disease","volume":"18","author":"Titze-de-Almeida","year":"2018","journal-title":"Curr. Gene Ther."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.038_b0530","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"issue":"s1","key":"10.1016\/j.neuroscience.2025.01.038_b0535","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.3233\/JAD-220449","article-title":"Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease","volume":"94","author":"Tryphena","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0540","article-title":"Exosome-based drug delivery systems for enhanced neurological therapeutics","author":"Vahab","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0545","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2014.05.030","article-title":"Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b","volume":"69","author":"Villar-Men\u00e9ndez","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00391","article-title":"Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders","volume":"21","author":"Wang","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0555","doi-asserted-by":"crossref","first-page":"19670","DOI":"10.1038\/s41598-024-70758-z","article-title":"Identifying potential repurposable medications for Parkinson's disease through Mendelian randomization analysis","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0560","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1440-1681.13212","article-title":"MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1","volume":"47","author":"Wang","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.104972","article-title":"Pramipexole attenuates neuronal injury in Parkinson's disease by targeting miR-96 to activate BNIP3-mediated mitophagy","volume":"146","author":"Wang","year":"2021","journal-title":"Neurochem. Int."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.01.038_b0570","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/gtc.12877","article-title":"miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models","volume":"26","author":"Wang","year":"2021","journal-title":"Genes Cells"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.038_b0575","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/bpa.12267","article-title":"MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim","volume":"26","author":"Wang","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0580","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopha.2015.08.025","article-title":"MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting \u03b1-synuclein expression in MPTP-induced Parkinson's disease mouse","volume":"74","author":"Wang","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0585","first-page":"131","article-title":"Overexpression of miR\u2011185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK\/mTOR signaling pathway in Parkinson's disease","volume":"17","author":"Wen","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0590","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040836","article-title":"Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date","volume":"14","author":"Witika","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0595","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1159\/000495649","article-title":"Inhibition of microRNA-200a Upregulates the Expression of Striatal Dopamine Receptor D2 to Repress Apoptosis of Striatum via the cAMP\/PKA Signaling Pathway in Rats with Parkinson's Disease","volume":"51","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0600","article-title":"Plasma miR-153 and miR-223 Levels as Potential Biomarkers in Parkinson's Disease","volume":"16","author":"Wu","year":"2022","journal-title":"Front. Neurosci."},{"issue":"16","key":"10.1016\/j.neuroscience.2025.01.038_b0605","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1016\/j.cell.2023.06.004","article-title":"Development of an \u03b1-synuclein positron emission tomography tracer for imaging synucleinopathies","volume":"186","author":"Xiang","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.01.038_b0610","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/00207454.2020.1835899","article-title":"Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease","volume":"132","author":"Xie","year":"2022","journal-title":"Int. J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.038_b0615","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/kjm2.12241","article-title":"Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson's disease via activating NF-\u03baB signaling","volume":"36","author":"Xing","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0620","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.neurobiolaging.2013.09.027","article-title":"MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration","volume":"35","author":"Xiong","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0625","article-title":"Disease burden of Parkinson's disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021","volume":"46","author":"Xu","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0630","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.631553","article-title":"Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease","volume":"14","author":"Yang","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105218","article-title":"Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson's disease","volume":"148","author":"Yang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0640","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2019.11.008","article-title":"Mitophagy: A crucial modulator in the pathogenesis of chronic diseases","volume":"502","author":"Yang","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118159","article-title":"Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt\/GSK3\u03b2 signaling pathway","volume":"259","author":"Yang","year":"2020","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.038_b0650","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s11011-020-00546-x","article-title":"MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson's disease model by targeting Bax","volume":"35","author":"Yang","year":"2020","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0655","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","article-title":"MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease","volume":"15","author":"Yao","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0660","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1002\/brb3.2921","article-title":"microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease","volume":"13","author":"Yao","year":"2023","journal-title":"Brain Behav."},{"issue":"20","key":"10.1016\/j.neuroscience.2025.01.038_b0665","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl6442","article-title":"Molecular beacon-based detection of circulating microRNA-containing extracellular vesicle as an \u03b1-synucleinopathy biomarker","volume":"10","author":"Yu","year":"2024","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.038_b0670","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1080\/15548627.2017.1357792","article-title":"BNIP3L\/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2","volume":"13","author":"Yuan","year":"2017","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.01.038_b0675","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/cns.12589","article-title":"Lentivirus-Mediated Overexpression of MicroRNA-210 Improves Long-Term Outcomes after Focal Cerebral Ischemia in Mice","volume":"22","author":"Zeng","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.038_b0680","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.18632\/aging.102636","article-title":"HIF-1\u03b1\/microRNA-128-3p axis protects hippocampal neurons from apoptosis via the Axin1-mediated Wnt\/\u03b2-catenin signaling pathway in Parkinson's disease models","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0685","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12035-014-8950-z","article-title":"Neuroprotective Effects of \u03b2-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK\/Bcl-2\/Beclin-1 Pathway","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0690","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fncel.2017.00170","article-title":"Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease","volume":"11","author":"Zhang","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.038_b0695","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1080\/15548627.2019.1596480","article-title":"GORASP2\/GRASP55 collaborates with the PtdIns3K UVRAG complex to facilitate autophagosome-lysosome fusion","volume":"15","author":"Zhang","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.neuroscience.2025.01.038_b0700","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.12659\/MSM.914579","article-title":"miR-30c-5p Reduces Renal Ischemia-Reperfusion Involving Macrophage","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0705","article-title":"MicroRNAs: Game Changers in the Regulation of \u03b1-Synuclein in Parkinson's Disease","volume":"2019","author":"Zhao","year":"2019","journal-title":"Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.01.038_b0710","doi-asserted-by":"crossref","first-page":"14995","DOI":"10.1002\/jcb.28761","article-title":"MicroRNA-326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease","volume":"120","author":"Zhao","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"13","key":"10.1016\/j.neuroscience.2025.01.038_b0715","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/WNR.0000000000001494","article-title":"miR-132-5p regulates apoptosis and autophagy in MPTP model of Parkinson's disease by targeting ULK1","volume":"31","author":"Zhao","year":"2020","journal-title":"Neuroreport"},{"issue":"15","key":"10.1016\/j.neuroscience.2025.01.038_b0720","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2217\/epi-2019-0222","article-title":"\u03b1-synuclein accumulation in SH-SY5Y cell impairs autophagy in microglia by exosomes overloading miR-19a-3p","volume":"11","author":"Zhou","year":"2019","journal-title":"Epigenomics"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.038_b0725","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1159\/000495872","article-title":"MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson's Disease by Binding to AXIN1","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105197","article-title":"miR-103a-3p regulates mitophagy in Parkinson's disease through Parkin\/Ambra1 signaling","volume":"160","author":"Zhou","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.038_b0735","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030728","article-title":"Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson's Disease","volume":"20","author":"Zhu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.01.038_b0740","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/tox.23344","article-title":"Silencing of miR-497-5p inhibits cell apoptosis and promotes autophagy in Parkinson's disease by upregulation of FGF2","volume":"36","author":"Zhu","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.neuroscience.2025.01.038_b0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-024-01785-0","article-title":"Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes","author":"Zhuo","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.038_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010090","article-title":"MiR-155: An Important Regulator of Neuroinflammation","volume":"23","author":"Zingale","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.038_b0755","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/02652048.2022.2051626","article-title":"The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review","volume":"39","author":"Zuglianello","year":"2022","journal-title":"J. Microencapsul."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222500048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222500048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:46:34Z","timestamp":1777265194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222500048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":150,"alternative-id":["S030645222500048X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.038","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in Parkinson\u2019s disease: From pathogenesis to diagnostics and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}